$144 Million is the total value of Single Point Partners, LLC's 63 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SCHX | SCHWAB STRATEGIC TRus lrg cap etf | $332,000 | -20.4% | 5,423 | 0.0% | 0.23% | -9.1% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $29,000 | -49.1% | 12,000 | 0.0% | 0.02% | -42.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-04-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES INC | 16 | Q3 2023 | 30.2% |
| ISHARES TR | 16 | Q3 2023 | 20.3% |
| SPDR S&P 500 ETF TR | 16 | Q3 2023 | 11.0% |
| ISHARES TR | 16 | Q3 2023 | 3.5% |
| ALPHABET INC | 16 | Q3 2023 | 3.2% |
| ALPHABET INC | 16 | Q3 2023 | 3.0% |
| JPMORGAN CHASE & CO | 16 | Q3 2023 | 2.3% |
| ISHARES TR | 15 | Q3 2023 | 10.1% |
| SPDR INDEX SHS FDS | 15 | Q3 2023 | 5.6% |
| SPDR S&P MIDCAP 400 ETF TR | 15 | Q3 2023 | 1.2% |
View Single Point Partners, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-11 |
| 13F-HR | 2023-10-12 |
| 13F-HR | 2023-07-10 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-01-10 |
| 13F-HR | 2022-10-07 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-04-28 |
| 13F-HR | 2022-01-27 |
View Single Point Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.